Table 2.
Characteristics of study patients [median (range)] and plasma samples.
| Demographic data | |
| Number of patients | 30 |
| Sex | 18 male, 12 female |
| Age (years) | 25 (16–61) |
| Weight (kg) | 57 (46–86) |
| Height (cm) | 169 (149–186) |
| Lean body weight (kg)* | 46 (36–64) |
| Number of comedications per patient | 13 (7–21) |
| Pharmacokinetic data | |
| Number of total blood samples | 241 |
| Number of blood samples per patient | 8 |
| Itraconazole concentrations (mg l−1), range | 0.04–0.77 |
| Number of itraconazole concentrations | 111 (46.0%) |
| below LOD (LOD = 0.040 mg l−1) | |
| Capsules | 81 (33.6%) |
| Solution | 30 (12.4%) |
| Hydroxy-itraconazole concentrations (mg l−1), range | 0.04–0.86 |
| Number of hydroxy-itraconazole concentrations below LOD (LOD = 0.040 mg l−1) | 67 (27.8%) |
| Capsules | 50 (20.8%) |
| Solution | 17 (7.0%) |
Calculated as per Cheymol [34]. LOD, Limit of detection.